STAT+: AI drug developer Insilico Medicine and...
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks

Top 10 by votes · Updated hourly
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks

Whoever takes over the CDC next will face immediate and enormous challenges. Here are a few.

Marc Lipsitch and Yonatan Grad pay tribute to their former colleague and mentor Barry R. Bloom.

Major health insurers are trimming jobs, and Medicaid cuts could soon force hospitals to lay off workers.

Like it or not, PBMs are fiduciaries.

The next CDC director role, health care giants trimming jobs, and more news from Morning Rounds

The White House has drafted legislative text for its drug pricing policy and is sharing it with more than a dozen major pharmaceutical companies

A JAMA study details how lead lingers in the body and how it can elevate blood pressure, harm blood vessel lining, and raise risk of heart attack.

The American workforce has grown in large part thanks to the health care industry, but one key sector is cutting back.

Insilico's large deal with Eli Lilly, Takeda's Phase 3 psoriasis data, and more biotech news from The Readout

Get the 10 best reads every Sunday
Curated by AI, voted by readers. Free forever.